These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 230791)

  • 21. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between the level of cAMP and the contractile force under stimulation of alpha- and beta-adrenoceptors by phenylephrine in the isolated rabbit papillary muscle.
    Endoh M; Brodde OE; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):109-15. PubMed ID: 186721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of cAMP and positive inotropic effect evoked by isoproterenol under the graded inhibition of phosphodiesterase by papaverine in the isolated rabbit papillary muscle.
    Endoh M; Brodde OE; Schümann HJ
    J Mol Cell Cardiol; 1975 Sep; 7(9):703-11. PubMed ID: 171423
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of the benzimidazole derivative AR-L 115 BS on the activities of myocardial adenylate cyclase and phosphodiesterase preparations (author's transl)].
    Schuhmacher P; Greeff K; Noack E
    Arzneimittelforschung; 1982; 32(1):80-2. PubMed ID: 6277343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of papaverine on cyclic AMP, calcium uptake and force of contraction in isolated guinea-pig auricles.
    Holzmann S; Meinertz T; Nawrath H; Scholz H
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):443-50. PubMed ID: 191880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy.
    Chiu WC; Kedem J; Weiss HR; Tse J; Cheinberg BV; Scholz PM
    Cardiovasc Res; 1994 Sep; 28(9):1360-5. PubMed ID: 7954646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of ketamine on inotropic and chronotropic responsiveness of heart muscle.
    Adams HR; Parker JL; Mathew BP
    J Pharmacol Exp Ther; 1977 Apr; 201(1):171-83. PubMed ID: 191593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the inhibition by beta adrenergic receptor agonists of cyclic AMP phosphodiesterase activity of rat heart.
    Ain-Shoka AA; Buckner CK
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):269-78. PubMed ID: 28097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
    Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
    Ray A; MacLeod KM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
    Endoh M; Satoh K; Yamashita S
    Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological actions of APP 201-533, a novel cardiotonic agent.
    Salzmann R; Bormann G; Herzig JW; Markstein R; Scholtysik G
    J Cardiovasc Pharmacol; 1985; 7(3):588-96. PubMed ID: 2410694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive inhibition of phosphodiesterase activity by amrinone: its implication in the cardiac effect of the drug.
    Carpenedo F; Floreani M; Cargnelli G
    Pharmacol Res Commun; 1984 Oct; 16(10):969-77. PubMed ID: 6095329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular responses to a newly developed phosphodiesterase inhibitor, DN-9693 [7-pyperidinyl-1,2,3,5-tetrahydroimidazo (2,1-b)-quinazolin-2-one.HCl] in dog cross-circulated atrial and ventricular preparations.
    Akahane K; Furukawa Y; Haniuda M; Karasawa Y; Chiba S
    Jpn Heart J; 1989 Nov; 30(6):903-15. PubMed ID: 2561162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papaverine-induced positive inotropism with failure to increase cyclic AMP in rat atria.
    Aramendía P; Eisenschlos CD; Márquez MT
    Eur J Pharmacol; 1986 Nov; 131(1):141-4. PubMed ID: 3028824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides.
    Nemoz G; Prigent AF; Pacheco H
    Biochem Pharmacol; 1978; 27(24):2769-74. PubMed ID: 216370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.